FDA approves generic copy of Remeron anti-depressant

12/19/2003 | Forbes

Barr Laboratories announced the FDA approved its generic version of Akzo Nobel's Remeron, a drug to treat depression. With the approval, Barr has exclusive rights to sell its Soltab in the U.S. for the next six months.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI